Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects

SIMPLE SUMMARY: The clinical efficacy of neoantigen-reactive tumor-infiltrating lymphocytes and T cell receptor-engineered T cells (TCR-T) therapy is primarily attributed to the effective CD8(+) T cell responses that are limited to HLA-I presenting tumor-specific antigens. NK cells have the therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao, Yang, Xuejiao, Wang, Yueping, Chen, Yunshuo, Yang, Ying, Shang, Siqi, Wang, Wenbo, Wang, Yueying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818244/
https://www.ncbi.nlm.nih.gov/pubmed/36612246
http://dx.doi.org/10.3390/cancers15010251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818244/
https://www.ncbi.nlm.nih.gov/pubmed/36612246
http://dx.doi.org/10.3390/cancers15010251

Ejemplares similares